Related Experiment Video
Updated: Jan 11, 2026

06:26
Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.9K
Evaluating the impact of decentralized testing for tuberculosis in Ghana: A simulation model
Parastu Kasaie1, Lad Dombrowski2, Jeffrey Pennington1
1Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, United States of America.
PLOS Global Public Health
|November 17, 2025
Summary
Decentralizing tuberculosis (TB) molecular testing in Ghana improves diagnosis and treatment. Expanding Xpert MTB/RIF testing saves lives by reducing untested samples and misdiagnoses.
Area of Science:
- Public Health
- Epidemiology
- Health Systems Research
Background:
- Geographical inaccessibility to tuberculosis (TB) diagnostic services in Ghana hinders timely diagnosis.
- Decentralizing molecular testing for TB can improve case notification and treatment initiation, especially in underserved areas.
Purpose of the Study:
- To project the epidemiological impact of decentralized TB testing at the country level in Ghana.
- To evaluate the effects of expanding Xpert MTB/RIF testing to district-level facilities.
Main Methods:
- An individual-based simulation of Ghana's TB diagnostic system and treatment cascade was developed.
- The model was calibrated using District Health Information Management System (DHIMSII) data from 2019-2022.
- Two decentralization scenarios were assessed against the current diagnostic network.
Main Results:
- Under the baseline, 26% of samples were untested, with over 30% of diagnoses relying on clinical judgment and 35% false positives.
- Decentralizing Xpert to district hospitals reduced untested samples to 20% and false positives to 32%, potentially saving 43 lives per million by 2030.
- Full decentralization to all facilities could eliminate untested samples, reduce false positives to 25%, and save 180 lives per million by 2030.
Conclusions:
- Decentralizing Xpert MTB/RIF testing significantly improves diagnostic accuracy and TB treatment outcomes.
- Wide-scale implementation is crucial to achieve the full benefits of decentralized TB diagnostics in Ghana.
- This strategy enhances TB case finding and reduces unnecessary treatments, ultimately saving lives.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis I
811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis III
901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
901

